Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.220
-0.020 (-1.61%)
At close: Dec 5, 2025, 4:00 PM EST
1.221
+0.001 (0.06%)
After-hours: Dec 5, 2025, 7:57 PM EST
Ocugen Employees
Ocugen had 95 employees as of December 31, 2024. The number of employees increased by 30 or 46.15% compared to the previous year.
Employees
95
Change (1Y)
30
Growth (1Y)
46.15%
Revenue / Employee
$56,526
Profits / Employee
-$673,895
Market Cap
381.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OCGN News
- 15 days ago - Ocugen CEO to Present at NobleCon21—Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference - GlobeNewsWire
- 4 weeks ago - Ocugen, Inc. (OCGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ocugen Provides Business Update with Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Ocugen: A Retinal Disease Juggernaut In The Making - Seeking Alpha
- 2 months ago - Why Ocugen Stock Zoomed 12% Higher Today - The Motley Fool
- 2 months ago - Ocugen Shares Are Trading Higher Monday: What's Going On? - Benzinga
- 2 months ago - Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - GlobeNewsWire